Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study

Bone marrow derived mesenchymal stromal cells (BM-MSCs) have emerged as a possible new therapy for Multiple Sclerosis (MS), however studies regarding efficacy and in vivo immune response have been limited and inconclusive. We conducted a phase I clinical study assessing safety and clinical and perip...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacobaeus, Ellen, Kadri, Nadir, Lefsihane, Katia, Boberg, Erik, Gavin, Caroline, Törnqvist Andrén, Anton, Lilja, Anders, Brundin, Lou, Blanc, Katarina Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947442/
https://www.ncbi.nlm.nih.gov/pubmed/31810187
http://dx.doi.org/10.3390/jcm8122102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947442/
https://www.ncbi.nlm.nih.gov/pubmed/31810187
http://dx.doi.org/10.3390/jcm8122102

Ejemplares similares